These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 14942290)
1. [Immunological properties of the P factor; distribution in the population of Trieste]. BELSASSO E; VALENTE G Riv Ist Sieroter Ital; 1952; 27(1):1-5. PubMed ID: 14942290 [No Abstract] [Full Text] [Related]
2. [Preliminary research on the distribution of the group-specific P factor in the population of Pulgia]. TANSELLA G Riv Ist Sieroter Ital; 1952; 27(4):304-7. PubMed ID: 13004826 [No Abstract] [Full Text] [Related]
3. [Research on the distribution of the P factor in the province of Genoa]. CANEPA G Arch Med Interna; 1952; 4(6):223-30. PubMed ID: 13093263 [No Abstract] [Full Text] [Related]
4. [Some data on changes in agglutinating properties of the factor P during the process of prolonged blood preservation]. BAGDASAROV VA Probl Gematol Pereliv Krovi; 1961 Dec; 6():49-51. PubMed ID: 13863910 [No Abstract] [Full Text] [Related]
5. [Determination of the P factor in blood stains]. SCHNUG G Dtsch Z Gesamte Gerichtl Med; 1952; 41(4-5):451-3. PubMed ID: 13043447 [No Abstract] [Full Text] [Related]
6. [Study of the blood factor P]. LILLE SZYSZKOWICZ I; TAYTSCH Z Pol Tyg Lek (Wars); 1951 Jun; 6(25-26):805-9. PubMed ID: 14875562 [No Abstract] [Full Text] [Related]
7. [P blood factors in the Vienna population 1951, determined with human natural anti-P serum]. SPEISER P; WEIGL B Klin Med Osterr Z Wiss Prakt Med; 1952 Feb; 7(2):4-61. PubMed ID: 14939523 [No Abstract] [Full Text] [Related]
8. [Distribution of blood groups, M N P properties, Rh factor and genotypes in the population of Trieste]. BELSASSO E; VALENTI G Sangue; 1951; 24(3):140-3. PubMed ID: 14876327 [No Abstract] [Full Text] [Related]
9. [Frequency of the capacity of furnishing an RP in the serum of blood bank donors and its relation to blood groups and Rh factor]. GALLO E; CALLEGARO A; CALAPAJ GG Boll Ist Sieroter Milan; 1959; 38():364-7. PubMed ID: 13849891 [No Abstract] [Full Text] [Related]
10. [Experimental studies on the P factor by means of natural anti-P heterosera]. ILLCHMANN-CHRIST A Dtsch Z Gesamte Gerichtl Med; 1957; 46(1):46-52. PubMed ID: 13427563 [No Abstract] [Full Text] [Related]
11. [Antibodies against factor P with a high titer in human blood]. GUTHOF O Klin Wochenschr; 1952 Aug; 30(31-32):763. PubMed ID: 13001102 [No Abstract] [Full Text] [Related]
12. Transfusion hazards; report of a case demonstrating A reaction to the P factor. DOCHAT GR Ohio State Med J; 1956 Sep; 52(9):940-1. PubMed ID: 13359027 [No Abstract] [Full Text] [Related]
13. [Distribution of blood groups and M and N properties in the Trieste population]. BELSASSO E; VALENTE G Riv Ist Sieroter Ital; 1951; 26(6):490-5. PubMed ID: 14942286 [No Abstract] [Full Text] [Related]
14. [ON THE APPEARANCE OF THE ERYTHROCYTIC P FACTOR DURING HUMAN ONTOGENESIS]. RUFFIE J; DUCOS J; MARTY Y; VERGNES H C R Hebd Seances Acad Sci; 1964 Feb; 258():2424-5. PubMed ID: 14138909 [No Abstract] [Full Text] [Related]
15. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE. BLUM L J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548 [No Abstract] [Full Text] [Related]
16. The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system. BLUM L; PILLEMER L; LEPOW IH Z Immun exp ther; 1959; 118():349-57. PubMed ID: 13801696 [No Abstract] [Full Text] [Related]
17. New humoral aspecific immunological factor: the properdin system. ZANGAGLIA O Riv Emoter Immunoematol; 1957; 4(3):215-27. PubMed ID: 13506459 [No Abstract] [Full Text] [Related]
18. [Properdin: a new blood protein; its importance in phenomena of aspecific immunological defense]. MURICCHIO C Ann Med Nav (Roma); 1958; 63(4):457-69. PubMed ID: 13595442 [No Abstract] [Full Text] [Related]
19. [Properdin mutations a risk factor for meningitis]. Seitsonen S; Helminen M; Jarva H; Meri S; Järvelä I Duodecim; 2010; 126(9):1071-5. PubMed ID: 20593630 [TBL] [Abstract][Full Text] [Related]
20. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation. Ruef J; Kuehnl P; Meinertz T; Merten M Platelets; 2008 Aug; 19(5):359-64. PubMed ID: 18791942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]